http://www.newstin.com/us/SEATTLE_GENETICS Organizing the News Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.com/tag/us/79213994 "Check out CRO-011 from Curagen . I work in a medical lab (not Curagen's) and I think it's the best of the lot," she writes. CRO-011 is an "armed antibody," which uses a monoclonal antibody to specifically target and kill... Fri, 03 Oct 2008 23:09:33 GMT http://www.newstin.com/tag/us/79213994 2008-10-03T23:09:33Z http://www.newstin.com/tag/us/79117902 Strategic Additions Strengthen Cooley's Venture Capital, Technology, Life Sciences and Clean Technology Leadership PALO ALTO, CA--(Marketwire - In addition to comprising the core of Heller's Venture Law Group (VLG) in these... Fri, 03 Oct 2008 13:00:00 GMT http://www.newstin.com/tag/us/79117902 2008-10-03T13:00:00Z http://www.newstin.com/tag/us/78792486 Seattle Genetics, a clinical stage biotechnology company, has appointed Elaine Waller as its new senior vice president of regulatory affairs and Christopher Pawlowicz as senior vice president of human resources, as well as the... Thu, 02 Oct 2008 02:52:19 GMT http://www.newstin.com/tag/us/78792486 2008-10-02T02:52:19Z http://www.newstin.com/tag/us/78711041 Investing in development-stage drugmakers is risky. So many candidates, so little cash Exelixis is a drug discovery machine. With a goal of adding three new compounds to the pipeline each year, Exelixis has no worries about... Wed, 01 Oct 2008 18:05:33 GMT http://www.newstin.com/tag/us/78711041 2008-10-01T18:05:33Z http://www.newstin.com/tag/us/77052524 BOTHELL, Wash.----Seattle Genetics, Inc. announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will present at the 2008 UBS Global Life Sciences Conference on Tuesday, September 23, 2008, at... Wed, 17 Sep 2008 13:26:11 GMT http://www.newstin.com/tag/us/77052524 2008-09-17T13:26:11Z http://www.newstin.com/tag/us/76442087 Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate Cancer Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate CancerTARRYTOWN, N.Y.NY-PROGENICS Progenics Pharmaceuticals,... Mon, 08 Sep 2008 10:12:32 GMT http://www.newstin.com/tag/us/76442087 2008-09-08T10:12:32Z http://www.newstin.com/tag/us/76153909 Posted on: Wednesday, 3 September 2008, 06:00 CDT Thomas Weisel Partners (NASDAQ: TWPG) (TSX: TWP), a global growth-focused investment bank, will host its Annual Healthcare Conference, September 3-5 at the Four Seasons... Wed, 03 Sep 2008 11:00:25 GMT http://www.newstin.com/tag/us/76153909 2008-09-03T11:00:25Z http://www.newstin.com/tag/us/75653198 Posted on: Wednesday, 27 August 2008, 09:01 CDT Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics, will present at two upcoming... Wed, 27 Aug 2008 14:01:27 GMT http://www.newstin.com/tag/us/75653198 2008-08-27T14:01:27Z http://www.newstin.com/tag/us/75181403 Wednesday August 20, 11:20 am ET By David Penn Stocks began Wednesday continuing to move lower after two days of retreat - though the selling so far is far more restrained that what we saw earlier in the week. One of the things... Thu, 21 Aug 2008 13:27:38 GMT http://www.newstin.com/tag/us/75181403 2008-08-21T13:27:38Z http://www.newstin.com/tag/us/73966088 Seattle Genetics, Inc. (Nasdaq:SGEN) announced that it has initiated a phase I clinical trial of SGN-70, a humanized monoclonal antibody targeting CD70 that is being developed as an investigational therapy for autoimmune... Thu, 14 Aug 2008 08:07:06 GMT http://www.newstin.com/tag/us/73966088 2008-08-14T08:07:06Z